Tsutomu Hirano

11PUBLICATIONS
6CO-AUTHORS
Predictive and prognostic markersPharmacogenomicsGene expression (incl. microarray and other genome-wide approaches)GlycoconjugatesFood properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 08, 2025
Clinical significance of small dense low-density lipoprotein cholesterol measurement in type 2 diabetes.

Tsutomu Hirano

|Aug 30, 2023
Prospective randomized comparative study of the effect of pemafibrate add-on or double statin dose on small dense low-density lipoprotein-cholesterol in patients with type 2 diabetes and hypertriglyceridemia on statin therapy.

Tsutomu Hirano, Toshiyuki Hayashi, Hiroe Sugita

|Jul 03, 2023
Hypertriglyceridemia contributes significantly to high prevalence of small dense LDL-cholesterol in patients with type 2 diabetes, even when LDL-C targets are achieved.

Tsutomu Hirano

|Apr 24, 2023
Clinical significance of skin autofluorescence for diabetic macroangiopathy and comparison with conventional markers of atherosclerosis: a cross-sectional and prospective study.

Ema Aoki, Takeshi Hirashima, Yuko Kumamoto

|Apr 05, 2023
The influence of triglycerides on small dense low-density lipoprotein cholesterol levels is attenuated in low low-density lipoprotein-cholesterol range: Implications for the negative results of the PROMINENT trial.

Tsutomu Hirano, Yasuki Ito

|Jan 28, 2023
No change in small low-density lipoprotein cholesterol levels with pemafibrate might explain the negative results of the PROMINENT trial.

Tsutomu Hirano

Pageof 2

Frequent Collaborators

4 joint publications

Michishige Terasaki

1 joint publications

Kengo Sato

1 joint publications

Hironori Yashima

1 joint publications

Yusaku Mori